Graham Ross Dallas Jones

Summary

Affiliation: St Vincent's Hospital
Country: Australia

Publications

  1. ncbi Effect of the reporting-interval size on critical difference estimation: beyond "2.77"
    Graham Ross Dallas Jones
    Department of Chemical Pathology, St Vincent s Hospital, Sydney, and Faculty of Medicine, University of New South Wales, Sydney, Australia
    Clin Chem 52:880-5. 2006
  2. ncbi Mass or molar? Recommendations for reporting concentrations of therapeutic drugs
    Graham R D Jones
    SydPath, St Vincent s Hospital, Sydney, NSW, Australia
    Med J Aust 198:368-9. 2013
  3. ncbi Study Protocol--accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR study
    Louise J Maple-Brown
    Menzies School of Health Research, Institute of Advanced Studies, Charles Darwin University, Darwin, Australia
    BMC Public Health 10:80. 2010
  4. ncbi A proposal for identifying the low renal uric acid clearance phenotype
    Praveen L Indraratna
    Faculty of Medicine, University of New South Wales, NSW, 2052, Australia
    Arthritis Res Ther 12:149. 2010
  5. ncbi Change of HbA1c reporting to the new SI units
    Graham R D Jones
    Department of Chemical Pathology, St Vincent s Hospital, Sydney, NSW
    Med J Aust 195:45-6. 2011
  6. ncbi Critical difference calculations revised: inclusion of variation in standard deviation with analyte concentration
    Graham Ross Dallas Jones
    Department of Chemical Pathology, SydPath, St Vincent s Hospital, Sydney, Darlinghurst, NSW, Australia
    Ann Clin Biochem 46:517-9. 2009
  7. ncbi Validation of the revised MDRD formula and the original Cockcroft and Gault formula for estimation of the glomerular filtration rate using Australian data
    Graham R D Jones
    Department of Chemical Pathology, SydPath, St Vincent s Hospital, Sydney, NSW, Australia
    Pathology 41:379-82. 2009
  8. ncbi Implementation of the routine reporting of eGFR in Australia and New Zealand
    Graham R D Jones
    Department of Chemical Pathology, St Vincent s Hospital, Sydney, Darlinghurst, NSW, Australia
    Scand J Clin Lab Invest Suppl 241:23-9. 2008
  9. ncbi Reporting units for therapeutic drug monitoring: a correctable source of potential clinical error
    Graham R D Jones
    Department of Chemical Pathology, St Vincent s Hospital, Sydney, NSW
    Med J Aust 186:420-1. 2007
  10. ncbi Reevaluation of the power of error detection of Westgard multirules
    Graham R D Jones
    Department of Chemical Pathology, St. Vincent's Hospital, Darlinghurst, NSW, 2010, Australia
    Clin Chem 50:762-4. 2004

Collaborators

  • Stephen M Twigg
  • Timothy Mathew
  • Hans Gerhard Schneider
  • David Wayne Johnson
  • Praveen L Indraratna
  • Louise J Maple-Brown
  • Kerin O'Dea
  • Sianna Panagiotopoulos
  • Katrina Drabsch
  • Kenneth M Williams
  • Richard J MacIsaac
  • Sophie L Stocker
  • Paul D Lawton
  • Garry G Graham
  • Wendy Hoy
  • Ashim K Sinha
  • Suresh K Sharma
  • Leigh C Ward
  • Alex Brown
  • Alan Cass
  • Robyn McDermott
  • George Jerums
  • Andrew G Ellis
  • Sajiv Cherian
  • Leonard S Piers
  • Jaquelyne T Hughes
  • Kevin Warr
  • Richard O Day
  • Mark Ab Thomas

Detail Information

Publications10

  1. ncbi Effect of the reporting-interval size on critical difference estimation: beyond "2.77"
    Graham Ross Dallas Jones
    Department of Chemical Pathology, St Vincent s Hospital, Sydney, and Faculty of Medicine, University of New South Wales, Sydney, Australia
    Clin Chem 52:880-5. 2006
    ..The influence of the size of the reporting interval on the critical difference (CD) between two results from the same patient has not been addressed previously...
  2. ncbi Mass or molar? Recommendations for reporting concentrations of therapeutic drugs
    Graham R D Jones
    SydPath, St Vincent s Hospital, Sydney, NSW, Australia
    Med J Aust 198:368-9. 2013
    ..These recommendations should also be applied to other supporting documentation such as published guidelines, journal articles and websites. The implementation of these recommendations in New Zealand is subject to local confirmation...
  3. ncbi Study Protocol--accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR study
    Louise J Maple-Brown
    Menzies School of Health Research, Institute of Advanced Studies, Charles Darwin University, Darwin, Australia
    BMC Public Health 10:80. 2010
    ....
  4. ncbi A proposal for identifying the low renal uric acid clearance phenotype
    Praveen L Indraratna
    Faculty of Medicine, University of New South Wales, NSW, 2052, Australia
    Arthritis Res Ther 12:149. 2010
    ..We also propose that a single daytime spot urine sample for calculation of fractional renal clearance of urate should be preferred to calculation from 24-hour urine collections...
  5. ncbi Change of HbA1c reporting to the new SI units
    Graham R D Jones
    Department of Chemical Pathology, St Vincent s Hospital, Sydney, NSW
    Med J Aust 195:45-6. 2011
    ..The SI units are a true measure of HbA(1c) and remove potential confusion between HbA(1c) values and blood glucose values...
  6. ncbi Critical difference calculations revised: inclusion of variation in standard deviation with analyte concentration
    Graham Ross Dallas Jones
    Department of Chemical Pathology, SydPath, St Vincent s Hospital, Sydney, Darlinghurst, NSW, Australia
    Ann Clin Biochem 46:517-9. 2009
    ..The calculation of the CD is re-examined without making this assumption...
  7. ncbi Validation of the revised MDRD formula and the original Cockcroft and Gault formula for estimation of the glomerular filtration rate using Australian data
    Graham R D Jones
    Department of Chemical Pathology, SydPath, St Vincent s Hospital, Sydney, NSW, Australia
    Pathology 41:379-82. 2009
    ..We aimed to assess these formulae using Australian data...
  8. ncbi Implementation of the routine reporting of eGFR in Australia and New Zealand
    Graham R D Jones
    Department of Chemical Pathology, St Vincent s Hospital, Sydney, Darlinghurst, NSW, Australia
    Scand J Clin Lab Invest Suppl 241:23-9. 2008
    ..The initial guidelines were released in August 2005 and these have been followed up in 2007 with further recommendations to address issues arising since that time...
  9. ncbi Reporting units for therapeutic drug monitoring: a correctable source of potential clinical error
    Graham R D Jones
    Department of Chemical Pathology, St Vincent s Hospital, Sydney, NSW
    Med J Aust 186:420-1. 2007
    ..This potential source of medical error needs to be addressed by all parties involved in communicating drug concentrations and providing support information...
  10. ncbi Reevaluation of the power of error detection of Westgard multirules
    Graham R D Jones
    Department of Chemical Pathology, St. Vincent's Hospital, Darlinghurst, NSW, 2010, Australia
    Clin Chem 50:762-4. 2004